Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ABT | MDT |
|---|---|---|
| Price | $101.69 | $89.11 |
| Change today | ▼ 1.74% | ▼ 0.21% |
| Market cap | $175.96B | $113.98B |
| Return, 3 months | +13.2% | +12.2% |
| Return, year to date | -17.3% | -5.6% |
| Return, 1 year | -22.3% | -3.9% |
| P/E (TTM) | 32.9 | 21.9 |
| P/B | 3.4 | 2.3 |
| P/E percentile vs own 5y | 69th | 10th |
| Dividend yield | 2.40% | 3.20% |
| Revenue growth (YoY, latest qtr) | +13.0% | +13.7% |
| Net profit growth (YoY) | -47.8% | +41.3% |
| Gross margin | 56.6% | 65.0% |
| Operating margin | 15.8% | 19.0% |
| Net margin | 11.6% | 13.9% |
| Return on equity | 10.7% | 10.7% |
| Analyst target vs. price | +22.3% | +16.9% |
| Analyst buy share | 100% | 63% |
| RSI (14) | 43 | 48 |
| 30-day volatility | 20.1% | 20.4% |
| Max drawdown, 1 year | -38.6% | -28.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.